Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDER Staffing Is Real Culprit Behind Missed User Fee Dates – FDA Official

Executive Summary

SAN DIEGO - Even with its new, more aggressive hiring campaign, the Center for Drug Evaluation and Research will take up to a year or more to become fully staffed, a CDER official said June 22 at the Biotechnology Industry Organization annual conference

You may also be interested in...



CDER New Drug Reviews Are At 80%-90% Of User Fee Goals, Jenkins Says

The Center for Drug Evaluation and Research's performance in review applications for new drugs and biologics within the timelines specified by the Prescription Drug User Fee Act has slipped to 80 percent to 90 percent

CDER New Drug Reviews Are At 80%-90% Of User Fee Goals, Jenkins Says

The Center for Drug Evaluation and Research's performance in review applications for new drugs and biologics within the timelines specified by the Prescription Drug User Fee Act has slipped to 80 percent to 90 percent

CDER New Drug Reviews Are At 80%-90% Of User Fee Goals, Jenkins Says

The Center for Drug Evaluation and Research's performance in reviewing applications for new drugs and biologics within the timelines specified by the Prescription Drug User Fee Act has slipped to 80 percent to 90 percent

Related Content

Latest News
See All
UsernamePublicRestriction

Register

PS049802

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel